Research Article

A Short Synthesis Concerning Biological Effects and Equivalent Doses in Radiotherapy

Cyril Voyant* and Daniel Julian

Published: 04/15/2017 | Volume 1 - Issue 1 | Pages: 039-045


The limits of classical equivalent computation based on time, dose, and fractionation (TDF) and linear quadratic models have been known for a long time. Medical physicists and physicians are required to provide fast and reliable interpretations regarding the delivered doses or any future prescriptions relating to treatment changes. In this letter, we propose an outline related to the different models usable for equivalent and biological doses that are likely to be the most appropriate. The used methodology is based on: the linear-quadratic-linear model of Astrahan, the repopulation effects of Dale, and the prediction of multi-fractionated treatments of Thames.

Read Full Article HTML DOI: 10.29328/journal.jro.1001005 Cite this Article


  1. Spotheim-Maurizot M, Mostafavi M, Belloni J, Douki T. Radiation chemistry: from basics to applications in material and life sciences. L’Editeur : EDP Sciences; 2008.
  2. Deutsch E, Vozenin MC. La radiobiologie, une discipline d’interface. Cancer Radiothér. 2011; 15: 347. Ref.:
  3. Steel GG. Basic Clinical Radiobiology. 3rd Revised edition. Hodder Arnold. 2002.
  4. Joubert A, Vogin G, Devic C, Granzotto A, Viau M, et al. Biologie des radiations. avancées majeures et perspectives pour la radiothérapie. Cancer Radiothér. 2011; 15: 348-354. Ref.:
  5. Foray N. Aspects radiobiologiques des traitements anticancéreux par rayonnement synchrotron: bilan et perspectives. Cancer/Radiothérapie. 2010; 14: 145-154. Ref.:
  6. Bourgier C, Heymann S, Vielh P, Azria D. Implications radiobiologiques de la classification moléculaire des cancers du sein: présent ou avenir? Cancer Radiothér. 2012; 16: 29-33. Ref.:
  7. Vogin G. Radiosensitivity, radiocurability and DNA repair. Cancer Radiothér. 2011; 15: 294-306. Ref.:
  8. Favaudon V. Radiobiology. Cancer Radiothér. 2000; 4: 333. Ref.:
  9. Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol. 1989; 62: 679-694. Ref.:
  10. Bruzzaniti V, Abate A, Pedrini M, Benassi M, Strigari L, et al. a tool for automatic calculation of biologically equivalent fractionation schedules in radiotherapy using IMRT with a simultaneous integrated boost (SIB) technique. J Exp Clin Cancer Res. 2011; 30: 52. Ref.:
  11. Bibault JE, Fumagalli I, Diaz O, Faivre JC, Leroy T, et al. The French Society of Young Radiation Oncologists: History, goals and perspective. Reports of Pract Oncol Radiother. 2012; 17: 255-258. Ref.:
  12. Gomez-Iturriaga A, Bilbao P, Casquero F, Cacicedo J, Crook J. Smartphones and tablets: Reshaping radiation oncologist’s lives. Reports of Pract Oncol Radiother. 2012; 17: 276-280. Ref.:
  13. Ellis P. Dose, Time and fractionation. A clinical hypothesis. Clin Radiol. 1969; 20: 1-6. Ref.:
  14. Liversage WE. A critical look at the ret. Br J Radiol. 1971; 44: 91-100. Ref.:
  15. Cosset JM. The come-back of hypofractionation? Cancer Radiothér. 2005; 9: 366-373. Ref.:
  16. Laszlo A, Rosset A, Hermann F, Ozsahin M, Zouhair A, et al. T.i.d. accelerated radiotherapy alone or alternating with chemotherapy in patients with a locally advanced ORL cancer: analysis of late toxicity. Cancer Radiothér. 2001; 5: 130-137. Ref.:
  17. Astrahan M. Some implications of linear-quadratic-linear radiation dose-response with regard to hypofractionation. Med Phys. 2008; 35: 4161-4173. Ref.:
  18. Dale RG. Radiobiological assessment of permanent implants using tumor repopulation factors in the linear quadratic model. Br J Radiol. 1989; 62: 241-244. Ref.:
  19. Thames HD. An incomplete-repair model for survival after fractionated and continuous irradiations. Int J Radiat Biol Relat Stud Phys Chem Med. 1985; 47: 319-339. Ref.:
  20. Van Dyk J, Mah K, Keane TJ. Radiation induced lung damage: dose time fractionation consideration. Radiot Onc. 1989; 14: 55-69. Ref.:
  21. Voyant C, Julian D, Roustit R, Biffi K, Marcovici CL. Biological effects and equivalent doses in radiotherapy: a software solution. Rep Pract Oncol Radiother. 2013; 29: 47-55. Ref.: